Paperpal Prime Logo

Neuromuscular Disorders : Impact Factor & More

eISSN: 1873-2364pISSN: 0960-8966

Aims and Scope of Neuromuscular Disorders

Neuromuscular Disorders is a peer-reviewed medical journal that focuses on neuromuscular disease, including muscular dystrophy, spinal muscular atrophy, and myasthenia. It is the official journal of the World Muscle Society. It was established in 1991 and is published by Elsevier. Less

Key Metrics

CiteScore
5.8
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Neurology
SNIP
1.31
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neuromuscular Disorders

Neuromuscular Disorders Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher PERGAMON-ELSEVIER SCIENCE LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1991
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Neuromuscular Disorders ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neuromuscular Disorders

Evaluation of antibody reactivity to dystrophin products: does Dp40 really exist?
  • 4 Aug 2026
  • Neuromuscular disorders : NMD
Longitudinal functional trajectories in Duchenne muscular dystrophy: outcome-specific patterns from a registry-based modelling study.
  • 1 Aug 2026
  • Neuromuscular disorders : NMD
Systematic review of outcome measures in facioscapulohumeral dystrophy (FSHD): validated, usable, and feasible tools for assessing function, performance, and strength.
  • 1 Aug 2026
  • Neuromuscular disorders : NMD
Clinical studies in 82 individuals with valosin-containing protein (VCP) associated multisystem proteinopathy and literature review.
  • 1 Aug 2026
  • Neuromuscular disorders : NMD
Severe dilated cardiomyopathy in females with dystrophinopathy : a case series of nine patients.
  • 1 Aug 2026
  • Neuromuscular disorders : NMD
Baseline characterisation of adults living with spinal muscular atrophy in the UK: insight from the Adult SMA REACH Real-World Data Collection Study.
  • 1 Aug 2026
  • Neuromuscular disorders : NMD
Evaluation of antibody reactivity to dystrophin products: does Dp40 really exist?
  • 4 Aug 2026
  • Neuromuscular disorders : NMD
Longitudinal functional trajectories in Duchenne muscular dystrophy: outcome-specific patterns from a registry-based modelling study.
  • 1 Aug 2026
  • Neuromuscular disorders : NMD
Systematic review of outcome measures in facioscapulohumeral dystrophy (FSHD): validated, usable, and feasible tools for assessing function, performance, and strength.
  • 1 Aug 2026
  • Neuromuscular disorders : NMD
Clinical studies in 82 individuals with valosin-containing protein (VCP) associated multisystem proteinopathy and literature review.
  • 1 Aug 2026
  • Neuromuscular disorders : NMD
Severe dilated cardiomyopathy in females with dystrophinopathy : a case series of nine patients.
  • 1 Aug 2026
  • Neuromuscular disorders : NMD
Baseline characterisation of adults living with spinal muscular atrophy in the UK: insight from the Adult SMA REACH Real-World Data Collection Study.
  • 1 Aug 2026
  • Neuromuscular disorders : NMD

FAQs on Neuromuscular Disorders